$Sonoma Pharmaceuticals, Inc.(SNOA)$ To that effect they have made some progress this year. In late March they announced receipt of 510(K) clearance from the FDA for their newest product Loyon Skin Descaler. The product is a patent-protected formulation of dry emollient Cetiol CC and medical silicone oil dimethicone which is intended for use in managing skin scaling seen in various types of dermatoses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
